Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Infacort
NEUROCRINE BIOSCIENCES INC
Healthy Subjects
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Glioma
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Bladder Transitional Cell Carcinoma
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Breast Cancer
1 trial -
Interferon beta-1a
BRIGHT MINDS BIOSCIENCES INC.
Healthy Subjects
1 trial -
Interleukin-2
Iovance Biotherapeutics B.V.
Chronic Graft Versus Host Disease
1 trial -
Intraperitoneal infusion of FAST CEA-targeted CAR-T
Chongqing Precision Biotech Co., Ltd
Colorectal Cancer
2 trials -
Invivo CAR-T
Chongqing Precision Biotech Co., Ltd
B-Acute Lymphoblastic Leukemia
1 trial -
Iopofosine I 131
Cellectar Biosciences
Breast Cancer
1 trial -
Isradipine
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
JADE101
Jade Biosciences
Healthy Volunteers
1 trial -
JADE101
Jade Biosciences
Healthy Volunteers (HV)
1 trial -
JADE201
Jade Biosciences
Rhematoid Arthritis
1 trial -
JDtic
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
KB301
Krystal Biotech Netherlands B.V.
Skin Roughness
1 trial -
KB407 (Nebulization)
Krystal Biotech Netherlands B.V.
Cystic Fibrosis
2 trials -
KB408 (Nebulization)
Krystal Biotech Netherlands B.V.
Alpha 1-Antitrypsin Deficiency
1 trial -
KK-LC-1 TCR-T cells
Iovance Biotherapeutics B.V.
Gastric Cancer
1 trial -
KNX100
BRIGHT MINDS BIOSCIENCES INC.
Healthy Volunteer Study
1 trial -
KYV-101 (Biological) - 0.33 Γ10^8 cells
Kyverna Therapeutics
Progressive Multiple Sclerosis
1 trial -
Kindolor Tosylate
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
L-dopa / carbidopa / entacapone (LCE)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
1 trial -
LB-100 for Injection
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Tumors
1 trial -
LB1901
Nanjing Legend Biotech Co.
T-Cell Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources